GMP Quality Policy and Regulatory Support
R&D Systems provides industry-leading quality and regulatory support for GMP ancillary and raw materials, including recombinant cytokines and growth factors, used in ex vivo cell therapy manufacturing. Using our experienced quality and manufacturing teams, our goal is to provide cell therapy manufacturers with a consistent, safe, and continuous supply of GMP-grade raw materials.... More Info
Supply Chain Continuity: GMP Proteins for Therapeutic Manufacturing
R&D Systems understands the critical nature of having a stable supply chain of Good Manufacturing Practices (GMP)-grade Proteins used as raw materials in the manufacturing of advanced therapies. This becomes progressively more important with the increased need that accompanies the transition from early stage to later stage clinical trials. We will work closely with you on forecasting, and in... More Info
Webinar - GMP Raw Materials for Cell Therapy: What, When, How?
Join our panel of experts Jean Stanton (J&J), John Tomtishen (Novartis), Dr. Sadik Kassim (Mustang Bio), and Dr. Diane Wotta (Bio-Techne) as they discuss: what GMP really means in the context of raw materials and ancillary reagents; the quality of raw materials required along the commercialization pathway; when to start using GMP materials; and the current regulatory landscape.
Learn more... More Info
Good Manufacturing Practices (GMP)-grade Proteins
As the promise of cellular therapies grows, so does the need for high-quality raw material and ancillary components for ex vivo cell manufacturing, including GMP cytokines and growth factors. Our large supply of GMP proteins is backed by our dedication to providing cell therapy manufacturers a consistent, safe, and traceable supply of reagents. View our GMP protein portfolio below... More Info
Good Manufacturing Practice (GMP) for Cell Therapy Manufacturing: What does this mean?
Several suppliers, including R&D Systems, offer growth factors and cytokines made specifically for culturing cells that will be used for cell therapy. They are only to be used during the cell culture process and residual protein is washed away before the cells actually come into contact with a patient. These reagents are commonly referred to as GMP (Good Manufacturing Practice), a term that... More Info
Cloudz™ Cell Activation Kits
Dissolvable Microspheres for Immune Cell Expansion in Cell Therapy
The robust ex vivo expansion of immune cells is a pivotal technique for the development and success of immune cell culture and immune cell therapies. R&D Systems is proud to provide a magnetic-free bead-based technology for the robust and reliable expansion of immune cells. Our pioneering Cloudz™ expansion technology... More Info
Regenerative Medicine using iPSCs: Setting Your Research Up for Success
Fabrizio Rinaldi, PhD, Scientist in Stem Cell Research and Development, Bio-TechneTim Manning, PhD, Proteins Product Manager, Bio-Techne
As induced pluripotent stem cells continue progress towards cell therapy use to treat neurodegenerative disease, diabetes, vision impairment, and heart repair, there are critical questions and steps for maintaining cell quality and consistency that need to... More Info
N21-MAX and N-2 MAX Media Supplement Trial Request
Fill out the request form to receive a free trial vial of either our N-2 MAX Supplement or any variant of our N21-MAX Media Supplements.
Learn More About N-2 MAX
Learn More about N-21 MAX
GMP N-2 MAX Media Supplement is manufactured using animal-free raw materials in an animal-free laboratory following cGMP guidelines. It performs just like the... More Info
Defining A Regulatory Path For Induced Pluripotent Stem Cells Based Cell Therapy
Kapil Bharti, PhD, National Eye Institute, Unit on Ocular Stem Cells and Translational Research
Induced pluripotent stem (iPS) cells are a potential source for developing autologous cell therapies. In this webinar, Dr. Kapil Bharti, provides a streamlined regulatory (cell manufacturing and preclinical) path towards filing an Investigational New Drug (IND) application to conduct a phase I... More Info
Cell and Gene Therapy
Discovery Solutions for Cell and Gene Therapy
Expand Your Research with an Eye to the Clinic
Advance your cell therapy research toward the clinic with the industry-leading quality and selection of R&D Systems® reagents and assays. You can rely on us to help smooth the path for your innovative strategies in immunotherapy or regenerative medicine. We have a proven track record of... More Info